Valsure
Valganciclovir hydrochloride USP (eq. to valganciclovir)
450 mg · film-coated tablets
Antiviral used for cytomegalovirus prophylaxis and treatment in transplant recipients.
At a glance.
| Brand name | Valsure |
|---|---|
| Composition | Valganciclovir hydrochloride USP (eq. to valganciclovir) |
| Strength | 450 mg |
| Dosage form | Film-coated tablets |
| Care segment | Transplant care |
| Pack size | 1 × 10 tablets |
| Storage | Store in a cool and dry place. Protect from light. |
| Schedule | Prescription only Verify schedule |
| Shelf life | TBC — client to supply |
| Manufactured by | Bioaltus Pharmaceuticals Pvt Ltd, Baddi, Distt. Solan (H.P.) |
What it is used for.
Antiviral used for prophylaxis and treatment of cytomegalovirus disease in solid organ transplant recipients.
Indication summary written for orientation only. Full prescribing information, dosing and contraindications are supplied to registered healthcare professionals on request.
Where it sits in the pathway
Related products.
Tacsure 0.5
Tacrolimus IP
0.5 mg · capsules
Calcineurin inhibitor for prophylaxis of organ rejection. Narrow therapeutic index.
Trough level View details Transplant careTacsure 1.0
Tacrolimus IP
1 mg · capsules
The 1 mg presentation, used alone or with the 0.5 mg strength to titrate to target trough.
Trough level View details Transplant careMofisure
Mycophenolic acid delayed-release USP
360 mg · delayed-release tablets
Antiproliferative immunosuppressant, used as part of a maintenance regimen after renal transplant.
Rejection risk ↓ View detailsNeed this product for a patient this week?
Tell us the unit and the quantity. We will confirm availability and the nearest stockist.